The BNF recently (2019) changed its guidance for the frequency of injections of hydroxocobalamin: Every 2 months in patients who have neurological symptoms Every 2 or 3 months when there are no neurological symptoms
Not suitable for children, pregnant women, breastfeeding women, or individuals with diabetes unless advised by a healthcare professional
GHK-Cu actively assists in angiogenesis (the formation of new blood vessels), fibroblast activity, and skin remodeling, which are all crucial for healthy, non-scarring recovery
Survey Data Show People Are Already Using These Peptides Hones survey confirms that the peptides on the FDAs agenda are already part of many Americans wellness routines, despite the lack of a clear prescription pathway
Beyond its role in reducing oxidative stress, glutathione (GSH) supplementation has been linked to improved insulin sensitivity (how effectively the body responds to insulin), which is associated with a reduced risk of diabetes
Food and Drug Administration warned compounders in 2019 not to use glutathione-L-reduced powder distributed by Letco Medical in Decatur, Alabama to compound sterile injectable drugs for patients